secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001104659-22-123694
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners appoints Atul Kavthekar as CFO effective Dec 12, 2022; interim CFO compensation set
--------------------------------------------------------------------------------

- Atul Kavthekar appointed CFO effective Dec 12, 2022; previously EVP/CFO at EyeCare Partners.
- Kavthekar receives $450K base salary, $50K signing bonus, option for 600K shares vesting over 4 years.
- Interim CFO Erin Darakjian receives $50K lump sum, option for 100K shares, bonus target increased to 50%.
- Darakjian retains role as Chief Accounting Officer and principal accounting officer after Kavthekar starts.
- Kavthekar entitled to six months' base salary severance if terminated without cause, subject to release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000110465922123694/0001104659-22-123694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000110465922123694/tm2231616d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-123694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer